🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
GT Biopharma, Inc.
Market Cap: Lowest
Employees: Lowest
Tri-specific Killer Engager (Tri KE) fusion protein
GT Biopharma, Inc. is a clinical stage biopharmaceutical company developing and commercializing immuno-oncology products using its proprietary Tri-specific Killer Engager (Tri KE) technology platform, with ongoing trials for GTB-3550 and preclinical studies for GTB-3650 and GTB-5550.
Website
About | Leadership | News | About | About | About | Leadership | Contact | Contact
Symbol: GTBP
Recent Price: $3.01
Industry: Biotechnology
CEO: Mr. Michael Martin Breen
Sector: Healthcare
Employees: 2
Address: 8000 Marina Boulevard, Brisbane, CA 94005
Phone: 415 919 4040
Leadership
- John Doe, CEO
- Jane Smith, CFO
- Emily Johnson, CTO
- Michael Brown, President
- Linda Davis, Chairman
- James Wilson, Director
- Michael Breen, Executive Chairman, Board of Directors, Interim Chief Executive Officer
- Jeffrey S. Miller, M.D., Consulting Senior Medical Director
- Alan L. Urban, Chief Financial Officer
Last updated: 2024-11-08